EUDAMED database

The EUDAMED (European Database on Medical Devices) is a mandatory, centralized IT system established by the European Union under the Medical Device Regulation (MDR, (EU) 2017/745) and the In-Vitro Diagnostic Medical Devices Regulation (IVDR, (EU) 2017/746). Its primary purpose is to increase transparency and traceability for all medical devices, including AI-based Software as a Medical Device (SaMD), throughout their lifecycle. It enhances market surveillance by competent authorities. The database consists of several interconnected modules for actor registration, UDI/device registration, clinical investigations, and post-market surveillance/vigilance. Within a risk management framework compliant with ISO 14971, EUDAMED serves as the central hub for vigilance reporting, mandating the submission of serious incident reports and Field Safety Corrective Actions (FSCAs), thereby ensuring timely communication of risks across the EU market.

Applying EUDAMED is a critical compliance step for enterprises to access the EU market. The implementation process involves three key stages: 1. **Actor Registration:** All economic operators (manufacturers, authorised representatives, importers) must first register in the actor module to obtain a unique Single Registration Number (SRN), which is a prerequisite for all subsequent activities. 2. **UDI/Device Registration:** Companies must assign a Basic UDI-DI and UDI-DI to each device and upload comprehensive device data, as specified in MDR Annex VI, into the UDI/device module. This creates a transparent and traceable record for each product. 3. **Vigilance and Post-Market Surveillance:** Integrate the company's Quality Management System (e.g., ISO 13485) with EUDAMED's vigilance module. This ensures that any serious incidents or FSCAs are reported within the strict regulatory deadlines (e.g., within 2 days for serious public health threats). Proper implementation can increase regulatory compliance rates to over 99% and reduce recall risks associated with data opacity by an estimated 25%.

Taiwanese enterprises, particularly SMEs, face several challenges with EUDAMED implementation: 1. **Data Complexity:** EUDAMED requires a vast amount of detailed lifecycle data for each device, far exceeding previous requirements. Existing data management systems are often inadequate for collecting and structuring this information efficiently. 2. **Regulatory Uncertainty:** The phased rollout and shifting timelines for mandatory use of EUDAMED modules create planning difficulties. Companies must constantly monitor European Commission updates to stay compliant. 3. **Resource Constraints:** Managing EUDAMED demands a blend of regulatory, IT, and data management expertise, which is often scarce. SMEs may lack the budget for dedicated personnel or specialized Regulatory Information Management (RIM) systems. **Solutions:** * **Priority Action:** Conduct a data gap analysis against MDR requirements, aiming to remediate critical data gaps within a 3-month timeframe. * **Strategy:** Adopt a scalable RIM solution or partner with expert consultants to build a compliant workflow. * **Organization:** Form a cross-functional task force to monitor regulatory changes and manage EUDAMED submissions.

Winners Consulting specializes in EUDAMED database for Taiwan enterprises, delivering compliant management systems within 90 days. Free consultation: https://winners.com.tw/contact